Generate Biomedicines, Inc. GENB Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax at other companies
Other financials
Where this comes from
Reported directly by Generate Biomedicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax.
The official record: Generate Biomedicines, Inc. ’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Generate Biomedicines, Inc. 's other comprehensive income unrealized holding gain loss on securities arising during period net of tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Generate Biomedicines, Inc. 's other comprehensive income unrealized holding gain loss on securities arising during period net of tax?
- Generate Biomedicines, Inc. (GENB) reported other comprehensive income unrealized holding gain loss on securities arising during period net of tax of -$82K in Q1 2026.